Literature DB >> 29991704

Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patients.

Gennaro Russo1, Ilaria Liguori1, Luisa Aran1, Giulia Bulli1, Francesco Curcio1, Gianluigi Galizia2, Gaetano Gargiulo3, Gianluca Testa1,4, Andrea Ungar5, Francesco Cacciatore1,6, Domenico Bonaduce1, Pasquale Abete7.   

Abstract

In the last years, guidelines for the treatment of hypertension recommended individualized blood pressure goals for geriatric population because of elderly susceptibility to adverse outcomes and higher mortality rate deriving from the excessive blood pressure lowering, especially in "frail" elderly. Recent findings from the SPRINT study, which demonstrated that intensive blood pressure lowering was associated with lower rates of cardiovascular events and mortality in both hypertensive fit and frail elderly subjects compared to standard treatment, heavily influenced the recent US guidelines. In SPRINT sub-study analysis of adults aged ≥75 years, the most controversial issue appears the method of blood pressure measurement, the selection of patients and related-frailty degree that appears to be very light. Accordingly, it has been described that light frailty is related to good outcomes in older adults. SPRINT findings in "frail elderly patients" cannot be applied to the clinical practice because this condition has been clearly under-estimated. Thus, frailty status should be routinely and correctly quantified in order to identify the frailty degree and to find the best harms-benefits balance of antihypertensive drug treatment in frail older adults.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29991704     DOI: 10.1038/s41371-018-0086-6

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  34 in total

Review 1.  Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment.

Authors:  Fabrizio Ricci; Raffaele De Caterina; Artur Fedorowski
Journal:  J Am Coll Cardiol       Date:  2015-08-18       Impact factor: 24.094

2.  Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial.

Authors:  Nicholas M Pajewski; Jeff D Williamson; William B Applegate; Dan R Berlowitz; Linda P Bolin; Glenn M Chertow; Marie A Krousel-Wood; Nieves Lopez-Barrera; James R Powell; Christianne L Roumie; Carolyn Still; Kaycee M Sink; Rocky Tang; Clinton B Wright; Mark A Supiano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-01-11       Impact factor: 6.053

3.  Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Authors:  Clive Rosendorff; Daniel T Lackland; Matthew Allison; Wilbert S Aronow; Henry R Black; Roger S Blumenthal; Christopher P Cannon; James A de Lemos; William J Elliott; Laura Findeiss; Bernard J Gersh; Joel M Gore; Daniel Levy; Janet B Long; Christopher M O'Connor; Patrick T O'Gara; Gbenga Ogedegbe; Suzanne Oparil; William B White
Journal:  Circulation       Date:  2015-03-31       Impact factor: 29.690

4.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

5.  Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study.

Authors:  Athanase Benetos; Carlos Labat; Patrick Rossignol; Renaud Fay; Yves Rolland; Filippo Valbusa; Paolo Salvi; Mauro Zamboni; Patrick Manckoundia; Olivier Hanon; Sylvie Gautier
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

7.  White-coat hypertension: a clinical review.

Authors:  Hilde Celis; Robert H Fagard
Journal:  Eur J Intern Med       Date:  2004-10       Impact factor: 4.487

Review 8.  SPRINT Trial Results: Latest News in Hypertension Management.

Authors:  William C Cushman; Paul K Whelton; Lawrence J Fine; Jackson T Wright; David M Reboussin; Karen C Johnson; Suzanne Oparil
Journal:  Hypertension       Date:  2015-11-09       Impact factor: 10.190

Review 9.  Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis.

Authors:  Jessica Weiss; Michele Freeman; Allison Low; Rochelle Fu; Amy Kerfoot; Robin Paynter; Makalapua Motu'apuaka; Karli Kondo; Devan Kansagara
Journal:  Ann Intern Med       Date:  2017-01-17       Impact factor: 25.391

10.  No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.

Authors:  Jane Warwick; Emanuela Falaschetti; Kenneth Rockwood; Arnold Mitnitski; Lutgarde Thijs; Nigel Beckett; Christopher Bulpitt; Ruth Peters
Journal:  BMC Med       Date:  2015-04-09       Impact factor: 8.775

View more
  7 in total

1.  Moving Frailty Toward Clinical Practice: NIA Intramural Frailty Science Symposium Summary.

Authors:  Jeremy Walston; Karen Bandeen-Roche; Brian Buta; Howard Bergman; Thomas M Gill; John E Morley; Linda P Fried; Thomas N Robinson; Jonathan Afilalo; Anne B Newman; Carlos López-Otín; Rafa De Cabo; Olga Theou; Stephanie Studenski; Harvey J Cohen; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2019-05-02       Impact factor: 5.562

Review 2.  A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective.

Authors:  Jinho Shin; Kwang-Il Kim
Journal:  Clin Hypertens       Date:  2022-06-15

3.  Frailty in Chinese older adults with hypertension: Prevalence, associated factors, and prediction for long-term mortality.

Authors:  Lina Ma; Li Zhang; Fei Sun; Yun Li; Zhe Tang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-14       Impact factor: 3.738

4.  Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?

Authors:  Damien Tharmaratnam; Christopher C Karayiannis; Taya A Collyer; Hisatomi Arima; Leslie A McClure; John Chalmers; Craig S Anderson; Oscar R Benavente; Carole L White; Ale Algra; Chris Moran; Thanh G Phan; Wei C Wang; Velandai Srikanth
Journal:  J Am Heart Assoc       Date:  2021-12-16       Impact factor: 6.106

5.  Management of Hypertension in the Elderly and Frail Patient.

Authors:  Luigina Guasti; Marco Ambrosetti; Marco Ferrari; Franca Marino; Marc Ferrini; Isabella Sudano; Maria Laura Tanda; Iris Parrini; Riccardo Asteggiano; Marco Cosentino
Journal:  Drugs Aging       Date:  2022-07-29       Impact factor: 4.271

Review 6.  Frailty and hypertension in older adults: current understanding and future perspectives.

Authors:  Pan Liu; Yun Li; Yaxin Zhang; Seyed Erfan Mesbah; Tong Ji; Lina Ma
Journal:  Hypertens Res       Date:  2020-07-10       Impact factor: 3.872

7.  Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people.

Authors:  Peter Hanlon; Neave Corcoran; Guy Rughani; Anoop S V Shah; Frances S Mair; Bruce Guthrie; Joanne P Renton; David A McAllister
Journal:  Lancet Healthy Longev       Date:  2021-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.